ArticleCancers2021

Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma.

Minggui Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.